Early clinical studies to explore candidate biomarkers in targeted cancer therapies
PhD ceremony: Ms. C.N.A.M. Oldenhuis, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Early clinical studies to explore candidate biomarkers in targeted cancer therapies
Promotor(s): prof. J.A. Gietema, prof. E.G.E. de Vries, prof. S. de Jong
Faculty: Medical Sciences
Currently, much information is becoming available from tumor cell biology research, opening opportunities for the development of specifically tumor targeting agents. In this thesis we studied the safety, tolerability and pharmacokinetics of two novel targeted agents in phase 1 studies. An oral angiogenesis inhibitor and the apoptosis inducing agonistic antibody mapatumumab both appeared safe in combination with chemotherapy. No pharmacokinetic interactions were seen. Further studies on this combination are therefore warranted.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
18 April 2024
PET-scan expert Jan Pruim benoemd tot Officier in Orde van Oranje Nassau
Hoogleraar medische beeldvorming Jan Pruim is bij zijn afscheid van het UMCG benoemd tot Officier in de Orde van Oranje Nassau. De koninklijke versierselen werden hem op woensdag 17 april uitgereikt door burgemeester Koen Schuiling van de gemeente...
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...